2023-505041-52-00已完成1 期
A trial to learn if different doses of REGN17092 are safe in healthy adults
Regeneron Pharmaceuticals Inc.1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2023年8月16日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 128
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Medical Affairs
Scientific
Regeneron Pharmaceuticals Inc.
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A trial to learn if REGN7999 is safe and well tolerated, and how it works in the body of healthy participants.2022-500398-15-00Regeneron Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc.64
招募中
1 期
A study to see how a single increasing dose of the oral drug AD-700 affects the ability of a CT scan to detect activated brown fat in healthy people2025-520584-41-00Adiposs S.A.18
招募中
2 期
A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)Venous Thromboembolism2023-508603-21-00Regeneron Pharmaceuticals Inc.93
招募中
1 期
A study to test whether multiple doses of BI 456906 have an effect on cardiac safety in people with overweight or obesity.2023-506375-10-00Boehringer Ingelheim International GmbH110
招募中
1 期
A study to test how different doses of BI 3731579 are tolerated by healthy people2024-517209-95-00Boehringer Ingelheim International GmbH40